Public Citizen's Sidney Wolfe Taking On Larger Role At FDA; Drugmakers Express Concerns (Medical News Today)
The Wall Street Journal on Friday examined how, to "the consternation of the drug industry," the appointment of "[d]rug-safety crusader" Sidney Wolfe to FDA's Drug Safety and Risk Management Committee could give one of the leading critics of the pharmaceutical industry "the ear of several health leaders and members of Congress expected to influence FDA policy in the Obama administration.

Level of FDA drug approvals in '08 called disappointing (Arizona Daily Star)
WASHINGTON Medicines for rare disorders and diagnosing diseases contributed to a jump in U.S. drug approvals last year from a quarter-century low in 2007.